Concall Intelligence

Life Insurance Corporation of India (LICI) delivered solid H1 FY27 results with Profit After Tax up 21.52% YoY to Rs 25,568 Crore and Net VNB expanding by 33.95% to Rs 6,846 Crore, driven by a higher share of non-participating products and improved persistency. Management continues to focus on margin expansion through product mix rebalancing and digital transformation.

GRP Limited delivered a strong Q2 and H1 FY27 performance characterized by robust consolidated revenue growth, significant PAT expansion, and stable operating margins around 11% despite severe raw material inflation and geopolitical headwinds. The integrated recycling platform, particularly the ramp-up of Pyrova Energy and the turnaround in the plastics business, is driving domestic expansion and reducing reliance on traditional export markets.

The investment thesis remains intact. Robust top-line growth of 39.9% YoY and USD revenue recovery ($58M, up 5%+ QoQ) validate the portfolio strategy. Stable gross margins, efficient R&D spending, and successful USFDA compliance updates support ongoing earnings momentum, though integration of recent acquisitions and uncommercialized facilities remain key monitors.

Aadhar Housing Finance delivered stable growth in H1 FY27, reporting an AUM of INR 326,433 Mn and PAT of INR 5,907 Mn backed by a 100% secured retail loan book and consistent spreads, despite an ESOP charge impacting reported profitability.

Max Estates Limited reported Q2 FY27 revenue of Rs 52.8 Cr and PAT of Rs 4.7 Cr, while booking strong pre-sales of Rs 2,092 Cr supported by 100% occupancy across operational commercial assets.

The investment thesis remains intact. Ceigall delivered robust YoY revenue growth (26.8%) and margin expansion (EBITDA margin up to 17.0% from 14.1%) in Q2 FY27. Execution momentum is supported by appointed dates received for three HAM projects aggregating ~INR 40,500 million, while diversification into renewables and T&D broadens the growth base.

One Point One Solutions Limited reported strong financial growth for Q2 FY2027, driven by organic growth, new client wins, higher-margin renewals, and scaling of its proprietary agentic AI platform, ResolX, alongside recent inorganic expansions.

Shree Pushkar Chemicals & Fertilisers Limited delivered a robust performance in Q2 FY27 with consolidated revenue of INR403.5 crores, registering a 58.2% YoY growth, driven by improved realizations, favorable product mix, and strong demand in both chemical and fertilizer segments. EBITDA surged by 87.7% YoY to INR49.2 crores with an OPM of 12.2%, while PAT grew by 98.4% YoY to INR35.7 crores. Operational highlights include the commercial production commencement at Unit 5 and

Titan Company Limited reported consolidated revenue of 20,614.0Cr and PAT of 2,392.7Cr for Q2 FY27, backed by robust growth across Jewellery, Watches, and TEAL. However, results include a notable non-operational credit of 671Cr from the fair valuation reduction of the Damas acquisition option liability due to regional volatility.

Mahindra & Mahindra delivered a strong quarter with double‑digit revenue and profit growth, high RoE and continued capacity expansion, but cites short‑term margin pressure in auto and farm businesses and rising financing costs as near‑term risks.

Isgec Heavy Engineering Limited delivered robust performance in Q2 and H1 FY27, backed by all-time high order books, strong export momentum, significant net debt reduction, and improved operating cash flows, although working capital intensity and project-based execution risks remain.

Dr. Agarwal's Health Care Limited delivered robust financial performance for H1 FY27, marked by 31.4% YoY revenue growth and a 57.9% YoY surge in PAT, driven by aggressive greenfield and organic expansion, high same-store sales growth, and specialized surgical volumes.

Augmont Enterprises Limited reported record profitability for Q2 FY27 with consolidated PAT at ₹120.3 Cr (up 7% YoY and 97.2% QoQ) and EBITDA at ₹181 Cr, achieved despite a 27.0% YoY decline in revenue to ₹15,835.5 Cr caused by a deliberate strategic shift toward high-margin scrap procurement and government restrictions on silver flows.

GHCL Textiles reported strong top-line and profitability growth for Q2 & H1 FY27, backed by stable domestic demand, timely cotton procurement, and capacity utilization near full capacity, though earnings were impacted by an exceptional loss from a godown fire.

Krishna Institute of Medical Sciences Limited (KIMS) reported robust top-line growth of 39.9% YoY for Q2 FY27, driven by expansion and higher IP/OP volumes, though profitability growth was muted with PAT up 5.1% YoY due to ongoing ramp-up costs in newer units and Karnataka clusters.

Hexaware Technologies reported Q3 CY26 revenue of $411.9 million (INR 3,933.1 crore), representing a sequential growth of 1.6% and YoY growth of 4.3% in dollar terms. Reported EBIT margin stood at 12.2% (13.8% adjusted), and reported PAT reached INR 429.4 crore. While growth was driven by Banking, Financial Services, and TPP, performance was constrained by softness in a GSE client and slower deal ramp-ups. The company narrowed its full-year EBIT margin guidance range to 13-13

Protean eGov Technologies reported steady revenue growth for Q2 FY27 driven by core tax, CRA, and identity services, while profitability remained constrained by upfront implementation investments and project rollout expenses for key RFPs.

JM Financial Limited reported steady operational progress in key segments like Affordable Home Loans and Private Markets, alongside a strong IPO pipeline, despite a sequential dip in consolidated profitability for Q2FY27.

Core sugar segment earnings showed strong resilience with PBIT surging 166% YoY to Rs 140.75 cr on better volumes and pricing. While distillery margins faced pressure due to static ethanol procurement prices against higher input costs, overall profitability advanced. The flagship 80,000 TPA PLA project remains on track for commercial commissioning in Q4FY27, supporting long-term diversification.

Kansai Nerolac Paints reported consolidated revenue of 2317.4Cr and PAT of 144.0Cr for Q2 FY2026-27, supported by healthy demand in automotive and infrastructure segments, though material costs and currency volatility pressured operating margins.

The thesis remains intact as organic growth continues to outpace the broader pharmaceutical market (IPM), gross and EBITDA margins are expanding steadily, and working capital days remain relatively stable despite timing impacts on specific government contracts.

The investment thesis remains intact based on structural volume growth drivers like the Palghar facility ramp-up and the upcoming Egypt plant expansion targeting high-margin export markets. While Q2FY27 EBITDA faced margin contraction YoY, top-line momentum remains strong, and strategic initiatives such as the entry into health and functional finished products via the CAREGEN partnership diversify future revenue streams.

Chemplast Sanmar reported a mixed operational quarter for Q2 FY27 with consolidated revenue growing 28.1% YoY to Rs 1,323.2 Cr and EBITDA turning positive to Rs 111 Cr, driven by strong performance in Specialty Paste PVC and Custom Manufactured Chemicals. However, the company continued to log a net loss of Rs 5.5 Cr due to persistent structural headwinds, high finance costs, and margin pressures in the Value-Added Chemicals and Suspension PVC segments.

Smartworks delivered strong top‑line growth and improved profitability in Q2 FY27, raised its FY27 revenue guidance and reaffirmed EBITDA margin targets, while emphasizing secured supply and high‑visibility contracted revenue.

Suyog Telematics reported steady Q2 FY27 operational performance with revenue at Rs 71.7 Cr and robust EBITDA margins of 60.1%, though PAT declined year-on-year due to higher finance and depreciation costs.

IRM Energy Limited delivered strong H1 FY27 results with 26% YoY revenue growth and 124% YoY PAT growth, driven by an improved sales mix, disciplined gas sourcing, and operating leverage. However, management highlighted caution for H2 FY27 due to temporary gas allocation disruptions from the revised HPHT methodology and geopolitical volatility.

Insecticides (India) Limited reported moderate top-line growth with revenue up 8% YoY to Rs 686.31 crore for Q2 FY27, while PAT declined by 5% YoY to Rs 56.17 crore. Working capital pressures remain evident with elevated inventory and trade receivables days.

Eveready Industries delivered steady Q2 FY27 performance with 10.7% YoY revenue growth and managed input cost pressures, though gross margins saw slight compression due to high raw material costs and product mix.

Ashiana Housing Limited reported a strong financial quarter ended 30th September 2026, supported by significant revenue recognition from project handovers like Ashiana Amarah Phase 1 and Ashiana Anmol Phase 3, alongside record-high quarterly booking values driven by senior living and conversion scaling.

Greenpanel Industries reported Q2 FY27 revenue of INR 411.7 crore with flat YoY PAT at -0.6 crore and compressed OPM of 6.7%, driven by pricing pressures, sluggish OEM demand, and higher-cost opening inventory. Management expects demand drivers to remain intact with mid-teen MDF volume growth for the full year, supported by retail momentum and upcoming festive pickup.

The growth thesis remains intact as Indo Count scales its new businesses in utility bedding and USA brands, achieving record-high quarterly revenue and profitability while surpassing initial FY27 guidance in the first half.

Advanced Enzyme Technologies delivered strong top‑line and profit growth in Q2 FY27, with revenue up 16% YoY and PAT up 14% YoY, supported by robust segment performance and margin expansion.

The core investment thesis remains intact. Order book expansion to Rs. 2,267.93 Mn and robust revenue growth validate strong industrial demand and execution capabilities. While margin pressures from rising input, logistics, and energy costs are visible, major capacity expansion is nearing completion to support growth.

Volume and profitability are under pressure sequentially and year-on-year, driven by a 17% QoQ volume decline and rising fuel costs (INR 1.82/K.Cal). Net debt has increased to INR 2,027 crore as expansion capital expenditure continues, though green power usage offers structural cost offsets.

IFB Industries Limited reported Q2 FY27 revenue growth of 14.0% YoY, but profitability declined significantly with PAT dropping 24.8% YoY and PBDIT contracting by 11.3%, driven by higher material costs, adverse forex movements, and margin pressure across the Home Appliances and Refrigeration divisions.

Krishival Foods Limited reported a strong Q2 FY27 performance with revenue growing 28.5% YoY to Rs 85.66 Cr and net profit increasing 17.6% YoY to Rs 6.82 Cr, supported by healthy growth across both the Krishival Nuts and Melt N Mellow ice cream divisions.

Sanathan Textiles reported a strong second quarter for FY27, driven by a significant ramp-up at the new Punjab facility and robust domestic demand after initial global volatility in Q1.

The investment thesis remains intact as order book visibility continues to expand strongly, touching INR 31,780 Mn as of October 31, 2026. Margins are stable with Q2FY27 EBITDA margin at 29.2% and ROCE (annualized) at 16.7%, reflecting solid execution despite capacity scale-up.

Capital Small Finance Bank reported strong performance for Q2 and H1 FY27, driven by 23.4% YoY growth in gross advances and improved net interest margins of 4.24%. Asset quality improved with gross NPA declining to 2.36% and net NPA to 1.12%, supported by a secured lending model and granular portfolio, despite weather-related sectoral concerns.

Chalet Hotels Limited reported Q2 FY27 core business revenue growth of 11% YoY and EBITDA growth of 13% YoY, driven by solid domestic corporate demand and MICE events, though headline consolidated results reflect a sharp YoY drop due to one-off residential project revenue booked in Q2 FY26. Management announced pipeline expansion and brand rebranding initiatives, while exercising a concessional tax regime option resulting in a sizeable deferred tax credit.

The investment thesis remains intact as management's vertical integration and transformation strategy deliver material expansion in profitability and returns. Gross margins, EBITDA margins, and ROCE are scaling up alongside investments in renewable energy and modern manufacturing capex, though working capital management and collections require close monitoring.

The investment thesis remains intact backed by a robust order book of Rs 2,45,766 Mn providing strong revenue visibility, solid execution capabilities across diversified segments, and healthy credit ratings (CRISIL AA / CARE AA+). However, elevated working capital days warrant careful monitoring.

M & B Engineering Limited reported strong consolidated financial performance for Q2 and H1 FY27, characterized by record revenues and double-digit growth in PAT and EBITDA, driven by momentum in both Phenix and Proflex divisions. Management remains optimistic about future performance, backed by capacity expansions, a robust order book, and expanding international capabilities.

Tenneco Clean Air India Limited reported strong financial growth for Q2 and H1 FY27, driven by robust volume growth, market share gains in clean air and ride performance segments, and disciplined operational execution. Despite inflationary pressures and public company transition costs, margins remained resilient, and the balance sheet stayed net debt-free with healthy cash conversion.

Marksans Pharma delivered a strong performance in Q2FY27 with operating revenue of INR 940.2 cr, up 30.5% YoY, and EBITDA of INR 214.3 cr, up 48.3% YoY. Growth was driven by broad-based geographic expansion, notably in UK & Europe (helped by QliniQ and ABCnow acquisitions) and Australia & New Zealand, alongside a strong balance sheet and robust cash generation.

Galaxy Surfactants delivered a strong financial performance in Q2 FY27 with significant YoY growth in revenue, EBITDA, and PAT, driven by robust performance in India and AMET alongside strong momentum in Specialty Care. However, management remains cautious regarding raw material price volatility, tight feedstock availability, and geopolitical tensions in West Asia impacting global logistics.

The company continues its routine regulatory disclosures via earnings call transcripts for Q2/H1-FY2027. Detailed operational metrics, financials, and segment breakdowns are not explicitly contained within the provided cover letter text.

Carysil Limited delivered a consolidated revenue of Rs 275.7 Cr for Q2 FY27, representing a 14.6% YoY increase, while consolidated PAT after MI stood at Rs 28.4 Cr, up 4.3% YoY. Operating performance reflects steady manufacturing capacity utilisation across quartz and stainless-steel sinks, alongside ongoing capital expansion projects expected by the end of FY27.

The investment thesis remains intact. Websol delivered robust YoY top-line and bottom-line growth, backed by high capacity utilization (91% in cells) and a solid order book of ₹1,280 crore. The balance sheet is strengthened by the full repayment of the IREDA term loan, and execution on the 4 GW greenfield expansion and TOPCon upgrade is progressing as planned.

IOL Chemicals and Pharmaceuticals Limited delivered strong Q2 FY27 performance with revenue of INR 795 crore and PAT of INR 65.1 crore, driven by healthy demand across pharmaceuticals and chemicals, improved product mix, and robust capacity utilization.